K43TW013123
Project Grant
Overview
Grant Description
DECENTRALIZING BREAST BIOPSY PROCEDURES FOR EARLY CANCER DIAGNOSIS IN RWANDA - PROJECTS SUMMARY/ABSTRACT BACKGROUND: WITH 2.3 MILLION NEW CASES PER YEAR, BREAST CANCER IS AMONG THE MOST DIAGNOSED CANCERS IN WOMEN GLOBALLY AND IS THE LEADING CAUSE OF CANCER MORTALITY IN LOW-AND MIDDLE-INCOME COUNTRIES (LMICS), INCLUDING RWANDA. BREAST CANCER OUTCOMES IN LMICS ARE FAR WORSE AS 33-90% OF WOMEN WITH BREAST CANCER PRESENT WITH ADVANCED-STAGE DISEASE, DUE TO DELAYS IN DIAGNOSIS EXACERBATED BY THE ABSENCE OF DECENTRALIZED BIOPSY SERVICES, FORCING PATIENTS IN RURAL AREAS TO TRAVEL TO TERTIARY CENTERS FOR DIAGNOSIS. CENTRALIZATION OF BREAST BIOPSY CREATES BOTTLENECKS AND DELAYS TREATMENT INITIATION. THE FEASIBILITY OF IMPLEMENTING DECENTRALIZED BREAST BIOPSY SERVICES AT DISTRICT (LEVEL II) HOSPITALS TO FACILITATE EARLY CANCER TREATMENT, SAVE LIVES, AND CREATE SUSTAINABLE IMPROVEMENTS IN BREAST CANCER CARE ACROSS RWANDA HAS NOT YET BEEN DEMONSTRATED. THIS RESEARCH ALIGNS WITH NATIONAL CANCER INSTITUTE’S FOCUS ON IMPLEMENTATION SCIENCE AND HEALTH SYSTEMS RESEARCH, CROSS DISCIPLINARY CAPACITY DEVELOPMENT IN RESEARCH METHODS FOR LMICS, AND TECHNOLOGY FOR CANCER CONTROL, IN ADDITION TO FOGARTY’S SUPPORT FOR GLOBAL HEALTH RESEARCH, PARTNERSHIPS, AND CAPACITY BUILDING. CANDIDATE: THIS EMERGING GLOBAL LEADER (K43) AWARD WILL TRANSITION THE CLINICIAN RESEARCHER AND FACULTY GENERAL SURGEON AT THE CENTER FOR EQUITY IN GLOBAL SURGERY, UNIVERSITY OF GLOBAL HEALTH EQUITY TO INDEPENDENCE IN STRENGTHENING BREAST CANCER CARE IN RWANDA THROUGH RIGOROUSLY RESEARCHED, LOCALLY RELEVANT INTERVENTIONS THAT INCREASE ACCESS TO EARLY CANCER BIOPSY, AND TIMELY, HIGH-QUALITY CARE. HE WILL GAIN ADDITIONAL TRAINING IN ADVANCED HEALTH SERVICES RESEARCH, QUALITATIVE RESEARCH AND IMPLEMENTATION RESEARCH, AND CLINICAL EPIDEMIOLOGY WITH PROCESS IMPROVEMENT. THIS K43 WILL SUPPORT HIS LONG-TERM CAREER GOALS BY OFFERING STRUCTURED TRAINING IN CRITICAL AREAS, GUIDANCE FROM LEADING GLOBAL EXPERTS, AND APPLIED RESEARCH EXPERIENCE TO ACCOMPLISH HIS SCIENTIFIC OBJECTIVES. RESEARCH: THE RESEARCHER WILL EVALUATE THE CAPACITY, DETERMINANTS, AND FEASIBILITY OF INTEGRATING DECENTRALIZED BREAST BIOPSY SERVICES INTO DISTRICT (LEVEL II) HOSPITALS ACROSS RWANDA THROUGH THE FOLLOWING AIMS: 1- QUANTITATIVELY EVALUATE THE CAPACITY AND ORGANIZATIONAL READINESS FOR DECENTRALIZED BREAST BIOPSY SERVICES AT DISTRICT HOSPITALS ACROSS RWANDA; 2- QUALITATIVELY ASSESS THE FACILITATORS AND BARRIERS TO IMPLEMENTING DECENTRALIZED BREAST BIOPSY SERVICES AT DISTRICT HOSPITALS ACROSS RWANDA; 3- TO ASSESS FEASIBILITY OF IMPLEMENTATION OF DECENTRALIZED BREAST BIOPSY SERVICES AT FIVE DISTRICT HOSPITALS. INNOVATION: DEFINING OPTIMAL MEANS TO REDUCE RELIANCE ON CENTRALIZED SYSTEMS, USING INNOVATIVE TECHNOLOGY-DRIVEN TRAINING TOOLS INCLUDING GAMIFICATION, SIMULATION, AND EXTENDED REALITY TO TRAIN, PIONEERING USE OF ORGANIZATIONAL READINESS TOOLS IN THE GLOBAL BREAST BIOPSY SPACE ARE INNOVATIVE. FEW GLOBAL SURGEONS ARE IN THE CANCER IMPLEMENTATION SCIENCE SPACE. DELIVERABLES AND FUTURE DIRECTIONS: THE RESEARCHER WILL PUBLISH 8 RELEVANT MANUSCRIPTS AND SUBMIT AN R01 PROPOSAL TO TEST THE IMPACT OF IMPLEMENTING DECENTRALIZED MODELS OF CARE ACROSS THE REGION.
Funding Goals
THE JOHN E. FOGARTY INTERNATIONAL CENTER (FIC) SUPPORTS RESEARCH AND RESEARCH TRAINING TO REDUCE DISPARITIES IN GLOBAL HEALTH AND TO FOSTER PARTNERSHIPS BETWEEN U.S. SCIENTISTS AND THEIR COUNTERPARTS ABROAD. FIC SUPPORTS BASIC BIOLOGICAL, BEHAVIORAL, AND SOCIAL SCIENCE RESEARCH, AS WELL AS RELATED RESEARCH TRAINING AND CAREER DEVELOPMENT. THE RESEARCH PORTFOLIO IS DIVIDED INTO SEVERAL PROGRAMS THAT SUPPORT A WIDE VARIETY OF FUNDING MECHANISMS TO MEET PROGRAMMATIC OBJECTIVES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Rwanda
Geographic Scope
Foreign
University Of Global Health Equity (Ughe) was awarded
Decentralized Breast Biopsy Services Early Cancer Diagnosis in Rwanda
Project Grant K43TW013123
worth $131,278
from Fogarty International Center in September 2025 with work to be completed primarily in Rwanda.
The grant
has a duration of 5 years and
was awarded through assistance program 93.989 International Research and Research Training.
The Project Grant was awarded through grant opportunity Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 9/24/25
Period of Performance
9/16/25
Start Date
8/31/30
End Date
Funding Split
$131.3K
Federal Obligation
$0.0
Non-Federal Obligation
$131.3K
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
K43TW013123
SAI Number
K43TW013123-2176488017
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NF00 NIH Fogarty International Center
Funding Office
75NF00 NIH Fogarty International Center
Awardee UEI
YD5JTHY9MEK5
Awardee CAGE
SGRM4
Performance District
Not Applicable
Modified: 9/24/25